2025-11-11T23:36:38-06:00 2024-12-31 LUCY XIA CPA 7283 PASEO CAPUCHINA CARLSBAD CA 92009 990 2024-01-01 731627787 SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS SOCA 8585318164 PO BOX 927631 SAN DIEGO CA 921927631 YI LIU PRESIDENT 8585318164 2025-11-11 1 0 LUCY XIA P00783763 8586998838 X 2024 2025-03-06 01:10:19Z SAPBA YI LIU PO BOX 927631 SAN DIEGO CA 921927631 262586 0 X HTTP://SABPA.ORG X 2002 CA SABPA'S PRIMARY MISSION AND MOST SIGNIFICANT ACTIVITIES ARE TO PROMOTE SCIENCE AND INNOVATION. (1). TO PROVIDE FORUMS FOR FACILITATING INTERACTION AND COMMUNCATIONS AMONG BIOTECHINAL PROESSIONALSIONALS IN GLBOAL SCIENCE AND TECHNOLOGY ARENA;(2). TO PROMOTE INTERACTION AND COLLABORATION IN SCIENCE AND TECHNOLOGY ACROSS THE PACIFIC REGIONS; AND(3). TO STIMULATE AND NURTURE THE INNOVATIVE IDEAS, CUTTING-EDGE TECHNOLOGIES, ENTREPRENEURSHIP AND BRINGING PUBLIC AWARENESS OF THE BENEFITS OF BIOMEDICAL RESEARCH. 22 22 0 30 0 0 7298 48380 164128 205481 4454 8725 10815 0 186695 262586 0 0 0 0 0 0 0 0 0 0 227141 0 227141 186695 35445 386915 422360 0 0 386915 422360 X SABPA'S PRIMARY MISSION AND MOST SIGNIFICANT ACTIVITIES ARE TO PROMOTE SCIENCE AND INNOVATION. (1). TO PROVIDE FORUMS FOR FACILITATING INTERACTION AND COMMUNCATIONS AMONG BIOTECHINAL PROESSIONALSIONALS IN GLBOAL SCIENCE AND TECHNOLOGY ARENA;(2). TO PROMOTE INTERACTION AND COLLABORATION IN SCIENCE AND TECHNOLOGY ACROSS THE PACIFIC REGIONS; AND(3). TO STIMULATE AND NURTURE THE INNOVATIVE IDEAS, CUTTING-EDGE TECHNOLOGIES, ENTREPRENEURSHIP AND BRINGING PUBLIC AWARENESS OF THE BENEFITS OF BIOMEDICAL RESEARCH. 0 0 127897 119998 The 20th San Diego SABPA BioPharma Conference (October 5, 2024)Address: Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CAFor the past 20 years, San Diego BioPharma Conference, the flagship event of SABPA, has witnessed the boom of the pharmaceuticals and biotechnology industry in one of the nation's premier innovation centers. From potential Nobel laureates and technologically disruptive inventors to entrepreneurs and multi-billion-dollar dealmakers, this annual conference has been featuring some of the most respectful figures in the fields. This year, the long-awaited in-person conference is back.Program highlights are as follows:1. Fireside Chats on Taking a Research Organization towards Commercialization2. Breakthrough Prize Winner achievements in Serial Innovation in Drug Development3. The journey From Academia to Industry in Neuroscience IPOs4. Discovering the transformative impact of Moores Cancer Center's New Director, a world-renowned Pancreatic SurgeonDelving into cutting-edge innovations like Next-Gen Chemo proteomics Platforms 72008 66077 The 8th Annual Frontiers in Therapeutics and Diagnostics (FTD) Forum (March 23, 2024)Address: Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CASABPA FTD annually brings together the latest in groundbreaking research, cutting-edge drugs, and industry trends within the biopharma sector. The event's broad spectrum of topics provides a platform for local biotech companies to engage in vibrant discussions and valuable networking opportunities. The forthcoming 8th FTD Conference was set to shine a spotlight on three revolutionary domains in the field of metabolism disease and oncology: Glucagon-like peptide-1 (GLP-1), Antibody-Drug Conjugates (ADC), and Minimal Residual Disease (MRD), each representing the forefront of innovations in therapeutics and diagnostics. Program highlights are as follows:1. GLP-1 receptor agonists, from diabetes to obesity and beyond2. The rise of ADC - a biological missile, for targeted cancer therapy3. Reinventing drug discovery with AI-powered automation4. Frontiers in MRD detection to increase chance of cancer cure 18994 19406 SABPA OC/LA 16th Annual Biomedical Forum (April 20, 2024)Address: The Beckman Center, 100 Academy, Irvine, CA, 92617SABPA OC/LA annually brings together the latest innovations in biomedical industries, cutting-edge developments of pharmaceuticals and medical devices, entrepreneurship, and career development. The event's broad spectrum of topics provides a platform for local biotech and medical device companies to engage in vibrant discussions and valuable networking opportunities. 218899 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 22 22 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 0 0 0 CA X YI LIU 8585318164 PO BOX 927631 SAN DIEGO CA 92192 X PETER Q HUANG BOARD CHAIR 5.00 X X 0 0 0 STEPHANIE SHI BOARD MEMBER 3.00 X 0 0 0 HUAINA LI BOARD MEMBER 3.00 X 0 0 0 YINGHONG GAO BOARD MEMBER 3.00 X 0 0 0 MINGZHU ZHANG BOARD MEMBER 3.00 X 0 0 0 WEIJUN SHEN BOARD MEMBER 3.00 X 0 0 0 JC XU BOARD MEMBER 3.00 X 0 0 0 HUA GONG BOARD VICE CHAIRMAN AND PRESIDENT 5.00 X X 0 0 0 YI LIU BOARD MEMBER 5.00 X X 0 0 0 MING GUO BOARD MEMBER 3.00 X 0 0 0 JASON WANG VICE CHAIR, PRESIDENT OF OC/LA CHAPTER 5.00 X X 0 0 0 HAOJUN FU VICE CHAIR 5.00 X X 0 0 0 HUI WANG BOARD MEMBER 3.00 X 0 0 0 PENGYU YANG BOARD MEMBER 3.00 X 0 0 0 JOCELYN YU BOARD MEMBER 3.00 X 0 0 0 DONG HAN BOARD MEMBER 3.00 X 0 0 0 JIAN LIU BOARD MEMBER 3.00 X 0 0 0 ANDREW WANG BOARD MEMBER 3.00 X 0 0 0 DAVID WALLACE BOARD MEMBER 3.00 X 0 0 0 TRACEY YEO BOARD MEMBER 3.00 X 0 0 0 ZHEN ZHU BOARD MEMBER 3.00 X 0 0 0 XIA DING SECTARY OF BOARD 5.00 X X 0 0 0 VIVIAN CHANG TREASURE CHAIR, OC/LA CHAP 5.00 X 0 0 0 YANG LIU TREASURE CHAIR, SD CHAPTER 5.00 X 0 0 0 DONGMEI HUANG PRESIDENT ELECT OF THE SD CHAPTER 5.00 X 0 0 0 WEIJUN FAN CFO 3.00 X 0 0 0 0 0 0 0 0 0 0 0 29466 18914 48380 BioPharma Conference 541900 119998 119998 Annual FTD Forum 541900 66077 66077 Annual Biomedical Foru 541900 19406 19406 205481 8725 8725 262586 205481 0 8725 140 140 15391 15391 5091 5091 1100 1100 483 483 909 909 EVENT SERVICE EXPENSES 164981 164571 410 EVENT PLANNING MEETINGS 21567 21567 CELEBRATION AND ACTIVIT 8002 170 7832 TELEPHONE AND INTERNET 2854 2854 6623 6623 227141 218899 8242 0 384640 420994 19576 18210 2275 1366 386915 422360 0 0 X 386915 422360 386915 422360 386915 422360 35445 0 X 0 0 0 X 52256 23978 7898 18113 48380 150625 52256 23978 7898 18113 48380 150625 150625 146 14 665 4454 8725 14004 164629 587108 0.91490 0.95070 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 15371 14136 1235 4205 4074 131 1366 Form 990, Part VI, Section B, line 11b After an initial draft of the form 990 is prepared, it is circulated for detail review and comment by the delegated Board members and the key management team who have responsibility and /or knowledge about the various matters disclosed and/or described in the form. The form 990 is filed with the IRS after the preview process is completed. Form 990, Part VI, Section B, line 12c SABPA has a "Code of Conduct" which covers the conflict of interest policy. A regular training of "Code of Conduct" is conducted to the key team members regularly. Form 990, Part VI, Section B, line 15 No compensation to any officers nor key employees. The entire organization is operated by volunteers. Form 990, Part VI, Section C, line 19 SABPA makes its governing documents, conflict of interest policy and financial statements available to the public through its own website upon request.